Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Date
2019-05-01Journal
The Lancet Infectious DiseasesPublisher
Lancet Publishing GroupType
Article
Metadata
Show full item recordIdentifier to cite or link to this item
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85064588607&origin=inward; http://hdl.handle.net/10713/10073ae974a485f413a2113503eed53cd6c53
10.1016/S1473-3099(18)30796-5
Scopus Count
Collections
Related articles
- Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.
- Authors: Peters PJ, Thigpen MC, Parise ME, Newman RD
- Issue date: 2007
- [Plasmodium falciparum resistant to sulfadoxine/pyrimethamine in Senegal].
- Authors: Botella de Maglia J, Valls Ferrer JM, Martínez Paz ML, Espacio Casanovas A
- Issue date: 1991 Feb
- Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania.
- Authors: Mutabingwa T, Nzila A, Mberu E, Nduati E, Winstanley P, Hills E, Watkins W
- Issue date: 2001 Oct 13
- Pharmacokinetics of sulfadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy.
- Authors: Nyunt MM, Adam I, Kayentao K, van Dijk J, Thuma P, Mauff K, Little F, Cassam Y, Guirou E, Traore B, Doumbo O, Sullivan D, Smith P, Barnes KI
- Issue date: 2010 Feb
- Intermittent preventive therapy for malaria in pregnancy: is sulfadoxine-pyrimethamine the right drug?
- Authors: Parikh S, Rosenthal PJ
- Issue date: 2010 Feb